Health-economic analysis of tocilizumab in patients with rheumatoid arthritis and systemic juvenile arthritis
Rationale. Rheumatoid arthritis (RA) and systemic juvenile arthritis (sJA) are the most frequent rheumatic diseases in adults and adolescents, consequently. Biologics disease modifying antirheumatic drugs (bDMARDs) are eff ective in treatment of RA and s JA. Aim. To perform health-economic analysis...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
Izdatelstvo OKI,
2020-05-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|